The 20 Best Medullary Thyroid Carcinoma Doctors Near Me in Wenatchee, WA
Find the Top Medullary Thyroid Carcinoma Experts and Specialists
The 20 Best Medullary Thyroid Carcinoma Doctors near Wenatchee, WA
MediFind found 5 doctor with experience in Medullary Thyroid Carcinoma near Wenatchee, WA. Of these, 3 are Experienced and 2 are Advanced.
Central WA Hosp Family Physicians
Lisa Stone is an Endocrinologist in Wenatchee, Washington. Dr. Stone is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Melasma, Adrenal Insufficiency Pediatric, Obesity in Children, and Hyperparathyroidism.
Central WA Hosp Family Physicians
Bindu Nayak is an Endocrinologist in Wenatchee, Washington. Dr. Nayak is rated as an Advanced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Type 1 Diabetes (T1D), Albright's Hereditary Osteodystrophy, Pseudohypoparathyroidism, and Hypothyroidism.
Confluence Health Hospital-Mares Campus
Abraham Sorom is a General Surgeon in Wenatchee, Washington. Dr. Sorom is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. His top areas of expertise are Familial Deafness, Hyperparathyroidism, Infant Hearing Loss, and Nasopharyngeal Carcinoma.
Confluence Health/Wenatchee Valley Hospital
Julie Smith is an Oncologist in Wenatchee, Washington. Dr. Smith is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Waldenstrom Macroglobulinemia, Paget Disease of the Breast, Breast Cancer, and Familial Colorectal Cancer.
Confluence Health/Wenatchee Valley Hospital
Lindsay Overton is a Hematologist in Wenatchee, Washington. Dr. Overton has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Medullary Thyroid Carcinoma. Her top areas of expertise are Primary Lymphoma of the Brain, Paget Disease of the Breast, Myelodysplastic Syndrome (MDS), and Large-Cell Immunoblastic Lymphoma.
Last Updated: 02/22/2026